5th Floor, Brigade Towers,
Financial District, Gachibowli,
Hyderabad - 500032,
India
Biopreservation Market - Growth, Trends, and Forecast (2019 - 2024)
The Biopreservation Market is segmented by Product (Biopreservation Media and Equipment), Application Area (Biobanking, Regenerative Medicine, Drug Discovery, and Other Application Areas), End User, and Geography.
- ABOUT THIS REPORT
- Biopreservation Market Snapshot
- Biopreservation Market Overview
- Scope of the Report
- Key Market Trends
- Competitive Landscape
- Major Players
- TABLE OF CONTENTS
Biopreservation Market Snapshot
Study Period:
2017-2025
Base Year:
2019
Fastest Growing Market:
Asia Pacific
Largest Market:
North America
CAGR:
15.3 %
Need a report that reflects how COVID-19 has impacted this market and its growth?
Biopreservation Market Overview
- The biopreservation market is expected witness a CAGR of 15.3% during the forecast period. Certain factors that are driving the market growth include improving healthcare expenditure, adoption of in-house sample storage in hospitals and labs, and increasing R&D investment.
- Healthcare expenditure continues to increase faster than economic growth in most countries, maintaining a trend observed over decades. The presence of equitable, responsive, and efficient health systems across North America, Europe, and Asia-Pacific has also contributed to the maximum possible share of GDP being utilized for healthcare expenditure. Biopreservation has broad public health and socio-economic impacts, and it is affecting many lives across the world. It has been widely used to preserve cells and tissues, targeting its applications in reproductive medicine and organ transplantation. Stem cell banking and gene banking have also gained global popularity. With the growing healthcare expenditure each year, the government collaborations with companies and universities, for better exposure to the technology used and its development for higher efficiency, are increasing. With growing technological advancements in biopreservation and healthcare equipment, along with cost effectiveness of these instruments, a major share of healthcare spending is going to be invested this domain.
- However, concerns with the transition from laboratory to the market include the major problems of preservation and storage of tissues or cells. Despite the protection, the processes of freezing and thawing often cause tissue damage or cell injury. This factor hinders the growth of the market potential of biopreservation. Tissue cryopreservation is highly complicated and difficult than cryopreservation of individual cells. Injuries to cells during freezing and thawing are related to the physicochemical and biophysical changes occurring during cryopreservation.
Scope of the Report
Biopreservation is a process that helps store biological samples for a longer period. Cells, tissues, and plasma are some of the common biological samples preserved through biopreservation.
| Products | |||||
| Biopreservation Media | |||||
|
| Application Area | |
| Biobanking | |
| Regenerative Medicine | |
| Drug Discovery | |
| Other Application Areas |
| End User | |
| Biobanks | |
| Hospitals | |
| Other End Users |
| Geography | ||||||||
| ||||||||
| ||||||||
| ||||||||
| ||||||||
|
Report scope can be customized per your requirements. Click here.
Key Market Trends
Biopreservation Media is Expected to Hold Significant Market Share in the Product Type Segment
Nutrient media has found wide application in stem cell therapy and transplanted organ preservation. Tissue engineering, which includes stem cell storage, has seen prominent usage of nutrient media. Early stage of stem cell culture depends on continuous supply of oxygen and nutrition diffusion. Stem cell engineering has been widely used for treating bone defects. Nutrient media has also been used exclusively for organ preservation and organ transportation. The most common approaches for organ preservation during an organ transplant are simple static cold storage (SCS) and hypothermic machine perfusion (HMP). They are approved for transplantation of liver, lungs, pancreas, heart, and kidney.
To understand key trends, Download Sample Report
North America Dominates the Market and Expected to do Same in the Forecasted Period
The North America market is primarily driven by the rise in demand for preservation of blood, solid tissue specimen, including paraffin-embedded or frozen bio-specimen of tumors, and other tissues, such as peripheral blood cells and bone marrow, along with stem cells-derived cord blood and its derivatives, across multiple research institutes, pathological centers, and hospitals. Favorable government regulations have also been observed in this region, which are supporting the sharing of biological samples.
To understand geography trends, Download Sample Report.
Competitive Landscape
The biopreservation market is highly competitive and consists of a number of major players. Companies, like BioCision LLC, BioLife Solutions Inc., Cesca Therapeutics Inc., Core Dynamics Ltd, Custom Biogenic Systems Inc., Lifeline Scientific Inc., Merck KGaA, Princeton CryoTech Inc., and VWR International, among others, hold the substantial market share in the market studied.
You can also purchase parts of this report. Do you want to check out a section wise price list?
Table Of Contents
1. INTRODUCTION
1.1 Study Deliverables
1.2 Study Assumptions
1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
4.1 Market Overview
4.2 Market Drivers
4.2.1 Improving Healthcare Expenditure
4.2.2 Adoption of In-house Sample Storage in Hospitals and Labs
4.2.3 Increasing R&D Investment
4.3 Market Restraints
4.3.1 High Cost of the Instruments and its Maintenance
4.3.2 Possibility of Tissue Injury During Preservation and Thawing
4.4 Porter's Five Forces Analysis
4.4.1 Threat of New Entrants
4.4.2 Bargaining Power of Buyers/Consumers
4.4.3 Bargaining Power of Suppliers
4.4.4 Threat of Substitute Products
4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
5.1 Products
5.1.1 Biopreservation Media
5.1.2 Equipment
5.1.2.1 Temperature Maintaining Units
5.1.2.2 Consumables
5.1.2.3 Other Products
5.2 Application Area
5.2.1 Biobanking
5.2.2 Regenerative Medicine
5.2.3 Drug Discovery
5.2.4 Other Application Areas
5.3 End User
5.3.1 Biobanks
5.3.2 Hospitals
5.3.3 Other End Users
5.4 Geography
5.4.1 North America
5.4.1.1 United States
5.4.1.2 Canada
5.4.1.3 Mexico
5.4.2 Europe
5.4.2.1 Germany
5.4.2.2 United Kingdom
5.4.2.3 France
5.4.2.4 Italy
5.4.2.5 Spain
5.4.2.6 Rest of Europe
5.4.3 Asia-Pacific
5.4.3.1 China
5.4.3.2 Japan
5.4.3.3 India
5.4.3.4 Australia
5.4.3.5 South Korea
5.4.3.6 Rest of Asia-Pacific
5.4.4 Middle East & Africa
5.4.4.1 GCC
5.4.4.2 South Africa
5.4.4.3 Rest of Middle East & Africa
5.4.5 South America
5.4.5.1 Brazil
5.4.5.2 Argentina
5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
6.1 Company Profiles
6.1.1 BioCision LLC
6.1.2 BioLife Solutions Inc.
6.1.3 Cesca Therapeutics Inc.
6.1.4 Core Dynamics Ltd
6.1.5 Custom Biogenic Systems Inc.
6.1.6 Lifeline Scientific Inc.
6.1.7 Merck KGaA
6.1.8 Princeton CryoTech Inc.
6.1.9 VWR International
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
*List Not Exhaustive
** Subject to Availability
**Competitive Landscape Covers - Business Overview, Financials, Products and Strategies, and Recent Developments
80% of our clients seek made-to-order reports. How do you want us to tailor yours?
LINKS
JOIN US
We are always looking to hire talented individuals with equal and extraordinary proportions of industry expertise, problem solving ability and inclination.
Interested? Please email us
[email protected]© 2020. All Rights Reserved to Mordor Intelligence.